Contact – Astante Therapeutics

Hit enter to search or ESC to close

Home
Team
Pipeline
Technology
- Articles & News
Contact Us

Contact Us

(509) 592-4664

Your name

Your email

Subject

Your message (optional)

Δ

Home
Team
Pipeline
Technology
- Articles & News
Contact Us

Recent Posts

An Enzyme‐Directed Imidazoquinoline for Cancer Immunotherapy
Comparing the immunogenicity of glycosidase-directed resiquimod prodrugs mediated by cancer cell metabolism
An Enzyme-Directed Imidazoquinoline Activated by Drug Resistance

© 2023 Astante Therapeutics.

Home
Team
Pipeline
Technology
- Articles & News
Contact Us